Clinical Trial Update: A Clinical Study Evaluating the Safety, Tolerability, Preliminary Efficacy and Immunogenicity of a Tumor Vaccine Injection Targeting Stressinducible Proteins MICA/B in Combination With the AG Regimen in Patients With Metastatic Pancreatic Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical study evaluating a MICA/B-targeted tumor vaccine with the AG chemotherapy regimen in metastatic pancreatic cancer; not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• AG regimen (Adriamycin/doxorubicin + gemcitabine) (doxorubicin + gemcitabine)
• MICA/B-targeted tumor vaccine

Snippet

Sponsor: The Third Xiangya Hospital of Central South University | Conditions: Pancreatic Cancer Metastatic | EARLY_Phase 1 | Status: NOT_YET_RECRUITING